© 2020 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2020 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
November 19, 2020
Recent research sheds light on the role of adjunctive long-acting injectable antipsychotics in treatment-resistant schizophrenia.
November 06, 2020
Data from a randomized phase III trial shows promise for new treatment strategy.
November 05, 2020
Researchers investigated in-hospital mortality and ICU admission in patients with COVID-19 with and without comorbid schizophrenia in a population-based cohort study.
October 07, 2020
Abnormal glutamate and GABA levels may underlie cognitive deficits. A recent study investigated these associations in a large group of antipsychotic-naïve patients with first-episode psychosis.
October 06, 2020
Schizophrenia is associated with an increased prevalence of alcohol use disorders. A post-hoc analysis of the clinical course of the 2 disorders is an important change in this understudied and often overlooked population.
September 30, 2020
Do neurological signs at illness onset predict long-term outcome schizophrenia?
September 21, 2020
Fewer women than men with major depressive disorder experience symptom relief with antidepressants. Is there a role for alternative therapies?
September 16, 2020
Does cognition predict outcomes in patients at clinical high-risk for psychosis?
September 14, 2020
The role of the oropharyngeal microbiome in schizophrenia and mania.
August 27, 2020
A nationwide cohort study sought to determine the clinical course of schizophrenia in women and men in order to improve diagnostic accuracy and design guidelines.